Paul E.l. Richardson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3410 Kimball Ave, Waterloo, IA 50702 Phone: 319-234-2649 Fax: 319-233-2430 |
Daniel Kwai Lee, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1717 W Ridgeway Ave, Waterloo, IA 50701 Phone: 319-233-0340 Fax: 319-233-0666 |
Dr. Eric John Askeland, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1717 W Ridgeway Ave, Waterloo, IA 50701 Phone: 319-233-0340 |
Anand H Inamdar, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3410 Kimball Ave, Waterloo, IA 50702 Phone: 319-234-2649 |
Dr. Mark Richard Newton, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2413 W Ridgeway Ave, Waterloo, IA 50701 Phone: 319-233-0340 Fax: 319-233-0666 |
News Archive
Guerbet (GBT), the contrast agent specialist for medical imaging, today announced that it had received approval from the U.S. Food and Drug Administration (FDA) for a new manufacturing plant for Lipiodol® (ethiodized oil) Injection, in Montreal, Canada.
Astellas Pharma Inc. and XenoPort, Inc. announced today that Regnite (gabapentin enacarbil) Extended-Release Tablets will be launched in Japan on July 10, 2012. Regnite is approved in Japan for the treatment of moderate-to-severe primary restless legs syndrome (RLS).
Two European Research Council (ERC) Starting Grants worth almost one and a half million euros each over the next five years have been awarded to two researchers from the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and the Charit Universit-tsmedizin, Berlin in Germany.
In a national clinical trial, adolescents with moderate to severe depression first given a placebo treatment and then an antidepressant medication alone or in combination with therapy responded just as well over the long term as participants who received active treatment throughout the study, UT Southwestern Medical Center researchers report.
› Verified 2 days ago